REGENEMED

regenemed-logo

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their patented, proprietary, core technologies enable in vitro growth of engineered human tissues, including liver, GI tract, bone marrow, blood-brain barrier, cardiovascular and neuronal. The first and critical application of these tissue-based in vitro model systems is to replace cell-based assays and animal testing to debottleneck ADME/Tox evaluation, the leading cause of drug failures facing the pharmaceutical industry.

#SimilarOrganizations #Financial #Website #More

REGENEMED

Industry:
Biotechnology Health Care

Founded:
2003-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.regenemed.com

Total Employee:
11+

Status:
Active

Contact:
8582009531

Email Addresses:
[email protected]

Total Funding:
1000 K USD

Technology used in webpage:
SPF LetsEncrypt Apache Google Maps HostPapa DNS


Similar Organizations

gene-sciences-inc-logo

Gene Sciences, Inc.

Gene Sciences Inc. is developing novel DNA targeted therapeutics for the treatment of human genetic diseases.

Investors List

tech-coast-angels_image

Tech Coast Angels

Tech Coast Angels investment in Venture Round - RegeneMed

tech-coast-angels_image

Tech Coast Angels

Tech Coast Angels investment in Venture Round - RegeneMed

Official Site Inspections

http://www.regenemed.com

  • Host name: 204.44.202.26
  • IP address: 204.44.202.26
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "RegeneMed"

RegeneMed - Crunchbase Company Profile & Funding

RegeneMed accelerates the development of safer, more effective drugs by โ€ฆSee details»

RegeneMed Inc. - Investors

RegeneMed is a privately held company incorporated in the State of California in 2003. The company was founded by the Co-Founder of Advanced Tissue Sciences (ATS) and the Lead โ€ฆSee details»

RegeneMed 2025 Company Profile: Valuation, Funding โ€ฆ

RegeneMed General Information Description. Operator of a biotechnology company intended to offer engineered human tissue-based assays. The โ€ฆSee details»

REGENEMED, INC.: Contact Details and Business Profile

REGENEMED, INC. is a Biotechnology, Business Services General, and Health Care company_reader located in San Diego, California with $2 million in revenue and 4 employees. โ€ฆSee details»

RegeneMed Inc. - TCA Venture Group

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Our โ€ฆSee details»

RegeneMed - 2025 Company Profile, Funding & Competitors

Apr 15, 2025 RegeneMed - Provider of engineered human tissue-based assays for research purposes. This company is not active anymore. Raised a total funding of $1M from 1 investor. โ€ฆSee details»

RegeneMed Company Profile | Management and Employees List

RegeneMed Profile and History. RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human โ€ฆSee details»

RegeneMed Inc.

RegeneMed tissue technologies are off-the-shelf available, scalable, reproducible and specific and designed to provide normal, diseased and polymorphic tissues. Additional applications โ€ฆSee details»

RegeneMed - Overview, News & Competitors | ZoomInfo.com

RegeneMed. Business Services · California, United States · <25 Employees . RegeneMed accelerates the development of safer, more effective drugs by providing integrated high โ€ฆSee details»

RegeneMed, Inc - VentureRadar

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Our โ€ฆSee details»

Regenemed Inc - Company Profile and News - Bloomberg Markets

Company profile page for Regenemed Inc including stock price, company news, executives, board members, and contact informationSee details»

RegeneMed Inc. - Contact Us

(858) 200-9530 (858) 200-9531. Dawn R. Applegate, Ph.D. Brian A. Naughton, Ph.D.See details»

Dawn Applegate - Owner - RegeneMed, Inc. | LinkedIn

Owner, RegeneMed, Inc. · Experience: RegeneMed, Inc. · Location: San Diego · 500+ connections on LinkedIn. View Dawn Applegateโ€™s profile on LinkedIn, a professional โ€ฆSee details»

RegeneMed Inc. โ€“ Funding, Valuation, Investors, News | Parsers VC

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Our โ€ฆSee details»

RegeneMed - Funding, Financials, Valuation & Investors

RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.See details»

RegeneMed - Contacts, Employees, Board Members, Advisors

RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.See details»

Careers | RegenMed

Careers THE COMPANY. RegenMed, headquartered in the United States and founded in 2014, develops long-term partnerships with physicians, medical associations, and product โ€ฆSee details»

RegeneMed - CoBee Company Profile & Funding Rounds

RegeneMed accelerates the development of safer, more effective drugs by providing integrated high throughput platforms incorporating engineered human tissue-based assays. Their โ€ฆSee details»

RegeneMed - Crunchbase

RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays. Search Crunchbase. Start Free Trial . Chrome โ€ฆSee details»

RegeneMed - Updates, News, Events, Signals & Triggers

RegeneMed develops drugs by providing integrated, high-throughput platforms incorporating engineered human tissue-based assays.See details»

linkstock.net © 2022. All rights reserved